Do Dopamine and Norepinephrine Problems Increase ADHD Risk of Addiction? 

Yes, individuals with ADHD face a significantly higher risk of developing addictions, and this vulnerability is closely tied to dopamine and norepinephrine dysfunction. These neurotransmitters are not only essential for attention and focus, but also for regulating reward, impulse control, and emotional stability, all of which are also key factors in substance use risk. 

Dopamine, Reward, and Self-Medication 

Dopamine is central to the brain’s reward system, helping us experience pleasure and anticipate rewards. In ADHD, low dopamine activity in regions like the striatum can cause a persistent feeling of under-stimulation or dissatisfaction. This can lead individuals to self-medicate with substances (such as nicotine, alcohol, or stimulants) in an unconscious attempt to boost dopamine levels and feel more “normal” or focused. Over time, this can lead to a pattern of dependence or compulsive use. 

Norepinephrine and Impulse Control 

Norepinephrine helps regulate arousal, stress response, and behavioural inhibition. When norepinephrine signalling is impaired, as it often is in ADHD individuals may have trouble resisting urges or considering long-term consequences. This loss of impulse control makes them more susceptible to risky behaviours, including substance misuse and other addictive tendencies. Together, dysfunctions in dopamine and norepinephrine systems increase comorbidity between ADHD and addiction, especially when the condition is undiagnosed or untreated. 

Visit providers like ADHD Certify for personal consultations to explore how managing neurotransmitter dysfunction can reduce addiction risk in ADHD.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Dopamine and norepinephrine systems.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.